Larson Financial Group »

Phathom Pharmaceuticals shares owned by Larson Financial Group

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.5k 797 8.12
2024-09-30 $12k 647 18.08

More positions owned by Larson Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Msci Eafe (IEFA)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Value Line Divid In SHS (FVD)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)

View all positions for Larson Financial Group

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Jennison Associates
Invesco
BlackRock
Carlyle
Vanguard Group
Ensign Peak Advisors
NEA Management Company
Daniel D. Thurber
Checkpoint Capital
Avidity Partners Management
Decheng Capital
Catalys Pacific
Jennifer Ranahan

View all funds holding Phathom Pharmaceuticals